06/27
Headlines

Jayne Crisman

Jayne Crisman is a Senior Analyst covering the Communication Services & Technology sector. Prior to joining Tech Insider in 2000, she worked at J.C. Bradford & Co. and Hoak Breedlove Wesneski & Co. covering wireless communications, and at Fidelity Investments before that. She is a five-time winner of the Wall Street Journal’s “Best on the Street” analysts survey, including ranking No. 1 in 2012 in the Telecommunications Equipment category.

Basic Material Active Runners: Newmont Mining (NYSE:NEM), Exxon Mobil Corporation (NYSE:XOM), Barrick Gold (NYSE:ABX), Petroleo Brasileiro Petrobras (ADR) (NYSE:PBR)

Jayne Crisman03 mins

That “ongoing” litigation stems from a lawsuit filed by the state of California against Newmont Mining Corp (NYSE:NEM) in July 2012. Filed by California Attorney General Kamala Harris, the suit states Newmont Mining Corp (NYSE:NEM) “owned and continued to have an interest in Empire Mine Park where they conducted mining operations, which have generated and…

Read More

NASDAQ Runners: Micron Technology (NASDAQ:MU), Zynga Inc (NASDAQ:ZNGA), FuelCell Energy Inc (NASDAQ:FCEL), Yahoo! Inc. (NASDAQ:YHOO)

Jayne Crisman02 mins

TheStreet Ratings team rates MICRON TECHNOLOGY INC as a Buy with a ratings score of B. Micron Technology, Inc. (NASDAQ:MU) stock performance was -1.48% in last session and finished the day at $21.91. Traded volume was 37.76million shares in the last session and the average volume of the stock remained 31.44million shares. The beta of…

Read More

Mid Cap Active Runners: Rite Aid Corporation (NYSE:RAD), Safeway Inc. (NYSE:SWY), Kinross Gold (NYSE:KGC), J.C. Penney Company (NYSE:JCP)

Jayne Crisman02 mins

Two families were displaced and three stores were destroyed in a five-alarm fire in Jersey City early yesterday morning. Two firefighters suffered smoke inhalation and were sent to the Jersey City Medical Center, where they were treated and released, Jersey City Assistant Public Safety Director Jerry Cala said. The second floor of a Rite Aid…

Read More

Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Jayne Crisman02 mins

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was…

Read More

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Jayne Crisman02 mins

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average…

Read More

Biotech Active Movers: Ariad Pharmaceuticals (NASDAQ:ARIA), Insmed Incorporated (NASDAQ:INSM), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals (NYSEMKT:INO)

Jayne Crisman02 mins

Earlier this week, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it has initiated a phase II pivotal study that will evaluate the safety and efficacy of AP26113 in locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who had previously been treated with Pfizer’s (PFE – Analyst Report) Xalkori (crizotinib). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)…

Read More